A61K36/29

PHENYLPROPANOID COMPOUND AND PREPARATION METHOD AND USE THEREOF

The present invention provides a phenylpropanoid compound and a preparation method and use thereof. The phenylpropanoid compound has a structural formula shown as formula (I), and the pharmaceutically acceptable salt has a structural formula shown as formula (II), formula (III), formula (IV), or formula (V). The phenylpropanoid compound and the pharmaceutically acceptable salt thereof have an effect on inhibiting a content of an inflammatory cytokine NO and an expression of an inflammatory cytokine TNF-, have an effect on inhibiting a hydroxyl radical (OH), thereby have anti-inflammatory and antioxidant activities, and has a good application prospect in preparing of a medicine for treating an inflammatory disease related to the above factors, such as cervicitis, endometritis, pelvic inflammatory disease, mastitis, sphagitis and/or arthritis.

##STR00001##

PHENYLPROPANOID COMPOUND AND PREPARATION METHOD AND USE THEREOF

The present invention provides a phenylpropanoid compound and a preparation method and use thereof. The phenylpropanoid compound has a structural formula shown as formula (I), and the pharmaceutically acceptable salt has a structural formula shown as formula (II), formula (III), formula (IV), or formula (V). The phenylpropanoid compound and the pharmaceutically acceptable salt thereof have an effect on inhibiting a content of an inflammatory cytokine NO and an expression of an inflammatory cytokine TNF-, have an effect on inhibiting a hydroxyl radical (OH), thereby have anti-inflammatory and antioxidant activities, and has a good application prospect in preparing of a medicine for treating an inflammatory disease related to the above factors, such as cervicitis, endometritis, pelvic inflammatory disease, mastitis, sphagitis and/or arthritis.

##STR00001##

Oral health care formulation and method of preparation thereof

Oral health care formulation and method of preparation for the same are disclosed herein. The disclosed oral care composition includes a combination of various herbs and minerals,and may be used to maintain good oral hygiene. Further, a method of oral health care is also disclosed in the various embodiments herein.

Oral health care formulation and method of preparation thereof

Oral health care formulation and method of preparation for the same are disclosed herein. The disclosed oral care composition includes a combination of various herbs and minerals,and may be used to maintain good oral hygiene. Further, a method of oral health care is also disclosed in the various embodiments herein.

COMPOSITIONS OF HERBAL FORMULATIONS AND USES THEREOF
20240285721 · 2024-08-29 ·

Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.

COMPOSITIONS OF HERBAL FORMULATIONS AND USES THEREOF
20240285721 · 2024-08-29 ·

Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.

Association between neopterin concentration and neurovascular charges in type-2 diabetes patients—effect of an Ayurvedic formulation mainly containing Berberis aristata

Provided herein are plant based formulations for the prevention and management of diabetic vascular complication The formulation include hydro-alcoholic extract of Berberis Aristata, Trigonella foenum-graceum and Salacia parviflora in an effective dose. Also provided herein are methods of using such formulations.

Association between neopterin concentration and neurovascular charges in type-2 diabetes patients—effect of an Ayurvedic formulation mainly containing Berberis aristata

Provided herein are plant based formulations for the prevention and management of diabetic vascular complication The formulation include hydro-alcoholic extract of Berberis Aristata, Trigonella foenum-graceum and Salacia parviflora in an effective dose. Also provided herein are methods of using such formulations.

Association between neopterin concentration and neurovascular charges in type-2 diabetes patients—effect of an Ayurvedic formulation mainly containing Berberis aristata

Provided herein are plant based formulations for the prevention and management of diabetic vascular complication The formulation include hydro-alcoholic extract of Berberis Aristata, Trigonella foenum-graceum and Salacia parviflora in an effective dose. Also provided herein are methods of using such formulations.

COMPOSITION FOR THE TREATMENT OF HUMAN AND MAMMALIAN ATHEROSCLEROSIS AND PATHOLOGICAL CALCIFICATION IN TISSUE
20180271805 · 2018-09-27 · ·

A compound for treatment of a disorder characterized by at least one of pathological calcification and/or plaque formation including a nutraceutical supplement and a sequestrant, wherein the compound does not include an antibiotic.